Sodium aurothiomalate
- Generic Name
- Sodium aurothiomalate
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C4H3AuNa2O4S
- CAS Number
- 12244-57-4
- Unique Ingredient Identifier
- HRS6S09A0H
- Background
Sodium aurothiomalate is a gold compound that is used for its immunosuppressive anti-rheumatic effects. Gold Sodium Thiomalate is supplied as a solution for intramuscular injection containing 50 mg of Gold Sodium Thiomalate per mL. It is most effective in active progressive rheumatoid arthritis and of little or no value in the presence of extensive deformities or in the treatment of other forms of arthritis.
- Indication
A disease-modifying antirheumatic drug (DMARD) indicated for the symptomatic treatment of arthritis.
- Associated Conditions
- Felty's Syndrome, Psoriatic Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis, Juvenile
- Associated Therapies
- -
Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2011-06-28
- Last Posted Date
- 2020-04-01
- Lead Sponsor
- Mayo Clinic
- Registration Number
- NCT01383668
Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer
- Conditions
- First Posted Date
- 2007-12-18
- Last Posted Date
- 2018-10-09
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 17
- Registration Number
- NCT00575393
- Locations
- 🇺🇸
Mayo Clinic - Jacksonville, Jacksonville, Florida, United States
🇺🇸Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
🇺🇸Mayo Clinic Cancer Center, Rochester, Minnesota, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.